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Background: Long-endurance exercises like ultramarathons are known to elicit various
metabolic and physiological changes in the human body. However, little is known about
very long-duration exercise at low intensities regarding healthy human subjects.
Aim: The purpose of this study was to evaluate changes in body composition and
metabolism in long-endurance but low-intensity events.
Methods: Twenty-five male and 18 female healthy recreational athletes (age
34.6 ± 8.8 years; BMI: 22.4 ± 2.0 kg/m2) of the “100 km Mammutmarsch” were
recruited for participation during the events in 2014–2016. Other than classical
ultramarathons, the “Mammutmarsch” is a hiking event, in which participants were
required to walk but not run or jog. It was expected to complete the 100-km
distance within 24 h, resulting in a calculated mean speed of 4.17 km/h, which fits
to the mean speed observed (4.12 ± 0.76 km/h). As not all participants reached
the finish line, comparison of finishers (FIN, n = 11) and non-finishers (NON, n = 21)
allowed differential assessment of performance. Body composition measured through
bioelectrical impedance analysis (BIA) was determined pre- and post-event, and serum
samples were taken pre-event, at 30, 70, and 100 km to determine NT-pro-BNP,
troponin T, C-reactive protein (CRP), cortisol, low-density lipoprotein (LDL), high-density
lipoprotein (HDL), triglycerides, total cholesterol, total creatine kinase (CK), CK-MB,
aminotransferase (AST), ALT, and sodium levels. Nineteen participants wore actimeter
armbands (SenseWear R©) to gain information about body activity and exercise intensity
[metabolic equivalent of task (MET)]. Sixteen participants wore mobile heart rate
monitors to assess mean heart rate during the race. Serum parameter alterations over
the course of the race were analyzed with mixed-effects ANOVA and additional t-tests.
All serum parameters were analyzed for correlation concerning different MET levels,
speed, age, BMI, baseline NT-pro-BNP, mean heart rate during the race, and sex with
linear regression analysis.
Results: We found significant elevations for muscle and cardiac stress markers (CRP,
CK, CK-MB, AST, ALT, cortisol, and NT-pro-BNP) as well as decreasing markers of
lipid metabolism (cholesterol, triglycerides, LDL). Although the intensity level demanded
from our participants was low compared with other studies on (ultra-) marathons, the
alteration of tested parameters was similar to those of high-intensity exercise, e.g., NT-
pro-BNP showed a fourfold increase (p < 0.01) and LDL decreased by 20% (p = 0.05).
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Besides the duration of exercise, age, BMI, training status, and sex are relevant
parameters that influence the elevation of stress factors. Notably, our data indicate that
NT-pro-BNP might be a marker for cardiovascular fitness also in healthy adults.
Conclusion: This low-intensity long-endurance walk evoked a strong systemic reaction
and large cell stress and shifted to a favorable lipid profile, comparable to higher intensity
events. Despite increasing cardiac stress parameters, there were no indications of
cardiac cell damage. Remarkably, the duration seems to have a greater influence on
stress markers and metabolism than intensity.
Keywords: body composition, cardiac stress, endurance, exercise performance, low intensity, physiological
changes, ultra-endurance, ultramarathon
INTRODUCTION
The knowledge about physiological changes in athletes
participating in ultramarathons is scarce. While thousands
of athletes compete in classic marathons, only a few hundred
do so in ultramarathons, i.e., distances longer than 42.195 km.
Nevertheless, in the last decades, the number of such events has
been increasing, as well as the number of athletes participating
in such events (Whyte, 2014; International Association of
Ultrarunners, 2020; Knechtle et al., 2020).
Several studies have shown that engaging in endurance
sports elicits various metabolic and physiological changes in
the human body. Changes in lean body mass and body fat
(Knechtle et al., 2008a; Baur et al., 2016), as well as a decrease
in serum lipids (Ginsburg et al., 1996), are considered beneficial
on diseases caused by western sedentary lifestyle, such as the
metabolic syndrome (Saklayen, 2018), while other alterations,
such as increases in cardiac and muscle cell damage markers
and markers indicating systemic inflammatory reaction, may
indicate adverse effects (Fallon, 2001; Scharhag et al., 2005, 2006;
Kasprowicz et al., 2013; Kłapcińska et al., 2013; Baur et al., 2016).
Established markers to assess these changes are creatine kinase
(CK), transaminases, C-reactive protein (CRP), and cortisol
(Allen et al., 2015; Cerqueira et al., 2020). Markers to assess
cardiac stress are NT-pro-BNP, released by cardiomyocytes in
response to stretching caused by volume load (Nakagawa et al.,
1995), and cardiac troponins, indicating myocardial damage
(Sarko and Pollack, 2002). These changes are discussed to be a
physiological response as cardiac and muscle cell markers return
to baseline shortly after finishing a marathon or ultramarathon,
suggesting rapid cell repair without adverse long-term effects
(Scharhag et al., 2005, 2006, 2008; La Gerche et al., 2008;
Kłapcińska et al., 2013).
However, the majority of these studies assessed triathlons,
marathons, or ultramarathons where participants ran or jogged
(Ohba et al., 2001; Wu et al., 2004; Scharhag et al., 2005; Scott
et al., 2009; Banfi et al., 2012; Kim et al., 2014; Salvagno et al.,
2014; Vilela et al., 2015; Emed et al., 2016; Yoon et al., 2016).
In those races, exercise intensity and, therefore, mean speed is
usually relatively high, e.g., around 14 km/h in 80-km races
(Zingg et al., 2015). In studies with lower mean running speed
around 5 km/h, distances were much longer (up to 308 km), but
participants still ran or jogged instead of walking (Kim et al.,
2014; Yoon et al., 2016). One study with a relatively low mean
speed covered a distance of up to 430 miles (≈690 km) but was
conducted in extremely cold weather (daily average temperatures
around −25◦C) (Coker et al., 2017).
Research concerning NT-pro-BNP in endurance exercise
showed levels exceeding its upper reference limit (URL) in 35.9%
of runners; however, only marathon and half-marathon races
were assessed (Vilela et al., 2015). Very few studies exist that
evaluated changes in NT-pro-BNP during ultramarathons. The
distances in existing studies varied between 60 (Salvagno et al.,
2014), 100 (Scharhag et al., 2005), 160 (Scott et al., 2009), and
280 km (Kłapcińska et al., 2013) up to 308 km (Kim et al.,
2014; Yoon et al., 2016) with running velocities varying from
8.5 to 10.0 km/h (Kasprowicz et al., 2013), respectively. Two
studies (Kim et al., 2014; Yoon et al., 2016) evaluating NT-
pro-BNP at lower intensities (i.e., walking instead of jogging or
running) covered more than triple the distance than the MM,
assessed in the present study. Another study covering exercise
at low intensities did not include healthy subjects but examined
patients with coronary heart syndrome, evaluated for only 30 min
(Scharhag et al., 2007). To our knowledge, no data covering
healthy athletes walking for a distance around 100 km exists.
Cardiac troponins have been analyzed in many studies
regarding half-marathon, marathon, and ultramarathon-runs
with increases in 51% of 1,045 evaluated athletes above the cut-
off value of 10 ng/L (Sedaghat-Hamedani et al., 2015). However,
participants of the evaluated ultramarathons were running at
jogging speed (9–10 km/h at a distance of 100 km) (Ohba et al.,
2001; Scharhag et al., 2005). Only few studies have evaluated
troponins at low-intensity and long-duration exercise. However,
in these few studies, participants were either heart patients
(Benda et al., 2016); were 55 years in mean age of which 82%
were prescribed diuretics, statins, or antihypertensive drugs; or
were of heterogenic age (21–82 years) of which 23% had cardiac
pathologies (Eijsvogels et al., 2010).
Regarding metabolic and stress parameters, several studies
have shown that ultramarathons may lead to a catabolic state
and fatigue with a decrease in triglycerides and cholesterol (Emed
et al., 2016) and increases of up to fourfold in cortisol (Baur
et al., 2016), 100,000 IU/L in CK, 40-fold in CRP, and 20-fold in
aspartate aminotransferase (AST) (Wu et al., 2004; Baur et al.,
2016). At present, only one study had included low-intensity
long-duration exercise at 60% of the participants’ VO2max, but
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included different disciplines like walking, cycling, and kayaking
(Marklund et al., 2013).
Thus, previous studies assessed multiple changes during
ultramarathons in which athletes tried to reach their personal
limits, e.g., running or jogging the longest possible distance in
48 h (Kłapcińska et al., 2013) or finish a certain distance as fast
as possible (Scharhag et al., 2005; Scott et al., 2009; Kim et al.,
2014; Salvagno et al., 2014; Baur et al., 2016; Yoon et al., 2016). As
walking and running speed correlate with exercise intensity [e.g.,
expressed in metabolic equivalent of task (MET)] (Ainsworth
et al., 1993; Mendes et al., 2018), the literature lacks information
concerning long-endurance exercise of low intensity, i.e., walking
instead of running among healthy human adults. While high-
intensity endurance exercises are clearly associated with the
elevation of diverse stress markers, it is questionable whether low-
intensity exercise over long distances might be less stressful and,
thus, more suitable for persons with pre-existing conditions, or
if such events of low intensity elicit significant changes among
metabolic and stress parameters in healthy humans at all.
In addition, the number of persons living a sedentary lifestyle
is increasing (Arocha Rodulfo, 2019), leading to numerous
adverse health effects like obesity and metabolic disorders
(Mayer-Davis and Costacou, 2001) where this western sedentary
lifestyle could be construed as an adverse environmental factor
(Wachira et al., 2018; Koohsari et al., 2020; Lin et al., 2020).
The purpose of this study was, therefore, to evaluate if and
to what extent changes in body composition and a wide range
of serum markers are evoked in healthy adult participants by a
24-h–100-km walking–march of low intensity. In addition, we
aimed to assess whether there were any correlations to individual
intensity, age, sex, and BMI.
It was the null hypothesis of this study that there would be
no significant changes in the evaluated parameters evoked by the
low-intensity exercise and that individual intensity, age, sex, and
BMI would not significantly influence the evaluated parameters.
The findings might further contribute to our understanding of
physiological processes of healthy human adults in response to
low-intensity long-duration exercise and could help recreational
athletes in their training as well as being applied in clinical
settings with respect to diseases of western sedentary lifestyle.
MATERIALS AND METHODS
Event
The “Mammutmarsch” (German for “Mammoth March,”
henceforth “MM”) is an ultramarathon challenging participants
to complete 100 km in less than 24 h (Mammutmarsch, 2018;
Maggioni et al., 2020). Other than in classical (ultra-) marathons,
the goal is not to finish the event as fast or as far as possible
to cure a winner, instead the participants are required to only
walk the entire distance. Therefore, the MM addresses leisure
athletes rather than professional (ultra-) marathon runners. As
the event is designed as a “march” without running or jogging, it
is leading to a continuous long-duration exercise of low intensity,
which marks the unique setting of this event. In 2016, around
2,000 athletes participated. The track consists of paved roads,
gravel roads, soft forestry paths, or cobblestones leading through
partly flat and partly hilly terrain into the rural areas around
the city of Berlin. As shown by GPS data from 2015 to 2016,
the track has an overall ascend and descend from 600 to 700 m
each, with an altitude profile from 7 to 85 m. In 2014, the march
led through the same terrain, with the same endpoint (Gusow,
Brandenburg, Germany).
Regardless of checkpoints along the track providing snacks
and water as well as benches to rest, all participants were
responsible for their own gear and provisions and thus carried
around 2–4 kg of equipment in a backpack.
Handicaps of the march were the long distance, the lack of
sleep, and cool temperatures especially at night. The events that
were part of this study took place on May 31/June 01, 2014, May
9/10, 2015, and May 14/15, 2016, starting at 5 pm and finishing
5 pm the next day. Temperatures ranged from 6◦C at night to
19◦C during the day with average temperatures of 14.3◦C in 2014,
13.3◦C in 2015, and 9.3◦C in 2016. In 2014 and 2015, conditions
were dry for 24 h, while in 2016, there was light drizzle (2 mm
over 3 h) at the end of the race.
As the conditions for all 3 years were similar concerning
temperature, weather, track, and season, all participants’ data
were pooled for statistical analysis.
Subjects
This study includes 43 healthy individuals of which were 25 male
and 18 female. All participants attended in the MM 2014, 2015,
and 2016. Due to issues relating to serum sample data collection,
out of the 43 subjects, 32 (19 male, 13 female) were included in
the serum sample data analysis.
Recruitment was conducted with support of the event
organizers. All participants received an email announcing
the study with a call for participation. Interested individuals
contacted the investigators via email and were provided with
information regarding the purpose of the study, methods, and
used equipment before enrolling. Participants were chosen in
the order they applied and with the purpose to achieve an
even distribution of females and males. There were no special
requirements to partake in the study – all adult participants were
eligible for inclusion in the study. All were recreational athletes;
some had a background of taking part in similar marches or other
long-endurance events.
The potential study participants were given appropriate time
to consider partaking in the study and to raise questions
or concerns. All gave their informed written consent to
partake in the study.
The study was approved by the Charité Ethics Board (review
number EA1/163/14), and all measurements and procedures
complied with the Declaration of Helsinki (54th Revision 2008,
Korea) regarding the treatment of human subjects.
Measurements
Baseline Assessment
Body mass, height, BMI, body composition, resting heart rate,
and serum parameters were measured pre-race in a standardized
laboratory environment indoors in an air-conditioned laboratory
(temperatures 18–21◦C) the week prior to the event. To assess
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training status with regard to our study, the participants filled
out a questionnaire about the distances covered per week on
foot (including both walking and jogging) of the previous
half year prior to the event and self-evaluated their endurance
capability on a rating scale from 1 to 10. Subjects were advised
to have fasted for 6–8 h and to abstain from sleep deprivation
the previous night as well as alcohol and drug consumption
(except for oral contraceptives for the female subjects) and from
caffeine consumption the morning of the test. Directly before the
measurements, participants were instructed to empty the bladder
and to remove all jewelry for pre-race measurements.
Anthropometric data were gathered with a calibrated scale
and height meter (Seca, Germany) on an even surface while
participants wore only minimal clothing (light underwear). Mean
resting heart rate was measured for all the participants with
a mobile heart rate monitor [RS800CX, Polar (Williams et al.,
2017)] in a supine position for 10 min.
Body composition was evaluated using bioelectrical
impedance analysis (BIA) via the tetra polar electrode method
with a BIA 101 device from AKERN, Italy (Lukaski and
Bolonchuk, 1988; Jaffrin and Morel, 2008). The BIA 101
measures resistance at a fixed constant sine current of 50 kHz
for the determination of reactance in human tissue and has been
clinically validated to allow the evaluation of body composition
(Segal et al., 1988) and provided a mobile platform of data
collection during our study. For quantification of fat mass, lean
tissue mass, and percent body fat, the formula of Segal et al.
for non-obese subjects was used. The equation is validated to
assess body composition in heterogeneous populations (Segal
et al., 1988). To assess total body water, the formula of Sun et al.
(2003) was applied. Measurements were conducted while the
participants were in a supine position after having laid down
for 10 min to allow equal redistribution of body fluids in all
instances, with minimal clothing and removed metals. For all
measurements, the right limbs were used. Undoubtedly incorrect
calculations (one participant) were excluded.
Serum samples were taken from cubital vein blood collections
in a Sarstedt S-Monovette R©, immediately chilled on ice (without
direct contact to the ice to avoid freezing), and stored in
a sealed cooling box. Directly after the race, samples were
centrifuged for 10 min at 2,000 × g. Afterward, they were
stored overnight at 4◦C and sent to the laboratory the
next day. The parameters NT-pro-BNP (pg/ml), troponin T
(ng/L), CRP (mg/L), cortisol (µg/dl), low-density lipoprotein
(LDL) (mmol/L), high-density lipoprotein (HDL) (mmol/L),
triglycerides (mmol/L), total cholesterol (mmol/L), total CK
(U/L), CK-MB (U/L), AST (U/L), ALT (U/L), and sodium
(mmol/L) were determined by a certified laboratory [Labor 28
GmbH, Berlin, Germany, accredited at the “DAkkS” (Deutsche
Akkreditierungsstelle GmbH), the national accreditation body
for the Federal Republic of Germany, pursuant to regulation (EC)
number 765/2008 and the accreditation body act of Germany]
(Deutsche Akkreditierungsstelle GmbH, 2020).
In-Race Measurements
Actimeter armbands (SenseWear R©) were given to 20 participants
in order to measure body activity parameters such as exercise
intensity {metabolic equivalent of task [1 MET = energy
expenditure with an oxygen consumption of 3.5 ml O2/kg/min,
resembling resting metabolic rate equal to 1 kcal/kg/h (Ainsworth
et al., 1993)]}, energy expenditure, steps, time of activity,
and duration of wearing the armband. Especially in cooler
environments (Van Hoye et al., 2014) and in light exercise
(Santos-Lozano et al., 2017) – like in the presented study –
the SenseWear armband can be considered an accurate tool
for assessment of energy expenditure. Each participant was
instructed how to wear the actimeter and to set a time
stamp right before starting and finishing the march. The
collected data were analyzed using the manufacturer’s software
(SenseWear Professional 7.0). From these data, mean walking
speed was determined.
To measure heart rate during the race, mobile heart rate
monitors [RS800CX, Polar (Williams et al., 2017)] were handed
out to 16 participants.
Serum samples were taken at 30 and 70 km checkpoints
and stored as mentioned above, and the same parameters were
determined as in the pre-race measurements. For the collection,
a pavilion with a bench and a table were set up at the checkpoints.
To reduce influence on serum parameters by consumed food or
fluids, the participants were instructed to neither eat nor drink
1 h before arriving at the checkpoints.
Post-race Measurements
Only for participants who reached the 70- or 100-km checkpoint,
post-measurements were performed.
Post-race measurements for participants who reached the 100-
km checkpoint were carried out within 30 min at the finishing
area; as for the earlier checkpoints, no foods or drinks were to
be consumed 1 h before reaching the finish and until completing
all measurements. For participants who dropped out at the 70-
km checkpoint, all post-measurements were carried out there.
The BIA measurements were conducted in the same manner
as during baseline assessment. After all participants finished the
march (or dropped out at an earlier stage), blood samples were
transported and centrifuged for 10 min at 2,000 × g. They were
stored overnight at 4◦C and sent to the laboratory the next day.
Statistical Analysis
Acquired data were analyzed using appropriate statistical
tests (mixed-effects analysis, t-test, and linear regression for
correlation analysis) with the statistical software GraphPad
Prism R©, Version 8, GraphPad Software Inc., United States.
We analyzed two groups accordingly to their performance:
participants who were able to finish the entire MM (FIN) and
participants who dropped out at an earlier stage (NON).
Differences in anthropometric data in FIN and NON-and
in between sexes were analyzed with an unpaired t-test. Body
composition pre- and post-race was analyzed with paired t-test.
All statistical analyses for serum parameters were carried out
with mixed-effects ANOVA. This mixed model uses a compound
symmetry covariance matrix and is fit using restricted maximum
likelihood (REML). In the absence of missing values, this method
gives the same p values and multiple comparisons tests as
repeated measures ANOVA. In the presence of missing values
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(missing completely at random), the results can be interpreted
like repeated measures ANOVA.
Additionally, to assess differences in between single time
points, paired t-tests were performed in FIN and NON.
Overall, these were the following numbers of cases in each
group:
– FIN: pre: n = 11; 30 km: n = 9; 70 km: n = 10; 100 km: n = 11
In 2014, only pre- and post-values were assessed, and in 2015,
one finishing participant missed the tent for collection of blood
samples at 30 km.
– NON: pre: n = 21; 30 km: n = 21; 70 km: n = 8; 100 km:
n = 0
Means at different time points between groups (FIN; NON) were
analyzed using unpaired t-tests.
All serum parameters were analyzed for correlation
concerning different MET levels, speed, age, BMI, baseline
NT-pro-BNP, mean heart rate during the race, and sex with
linear regression analysis. Regression lines were analyzed
regarding goodness of fit (r2), differences in increase or decrease
of parameters between the evaluated groups (slope), and
differences in overall levels of parameters between the evaluated
groups (y-intercept = elevation). If slopes differed too much,
it was not possible to calculate whether y-intercepts differed
significantly (“not computable” = “n.c.”).
Data of participants reaching the finish line after the 24-h time
limit were used for statistical analyses as well (n = 2).
Results are presented as means ± SD. Statistical significance
was assumed at p < 0.05.
RESULTS
Demographics and Performance
A total of 32 athletes out of the 43 (25 male, 18 female; age
33.4 ± 8.9 years; BMI: 23.6 ± 2.7 kg/m2; resting heart rate
66.7 ± 11.3 bpm) partaking in all three MM competitions
delivered usable serum samples and were included in the
statistical analysis. Out of those 32 athletes, 11 athletes
were able to complete the 100-km course (FIN) and 21
competitors withdrew during the race (NON), due to fatigue or
musculoskeletal complaints. Table 1 depicts demographic and
anthropometric data, as well as resting heart rate and the history
of weekly covered distance on foot of the half year prior to the
MM and the self-rated endurance capability of FIN and NON as
well as female and male participants.
In both groups, FIN and NON, males had a significantly
greater BMI than females. Additionally, in NON, male subjects
were significantly older, taller, and heavier than female subjects,
and the FIN group showed a more homogenous distribution
in demographic and baseline parameters. Individuals who were
able to finish the race (FIN) had a significantly lower BMI than
participants who dropped out at an earlier stage (NON).
On average, finishers needed 22.83 h to complete the race,
while the fastest male finisher ended after 21.68 h and the
TABLE 1 | Anthropometric data and demographics.
FIN
m f p (m vs. f)
n 7 4
Age (years) 35.9 ± 10.8 33.8 ± 4.8 0.72
Height (cm) 182.7 ± 11.0 176.8 ± 4.5 0.33
Weight (kg) 76.1 ± 8.6 68.3 ± 46.1 0.14
BMI (kg/m2) 22.8 ± 1.1 21.1 ± 0.5 < 0.02*
Resting heart rate (bpm) 69.0 ± 5.3 56.75 ± 10.1 0.09
Distance covered per week (km) 39.5 ± 5.1 79.3 ± 27.2 0.11
Endurance capability (self-rating,
1–10)
7.7 ± 0.2 7.5 ± 0.5 0.73
NON
m f p (m vs. f)
n 12 9
Age (years) 39.3 ± 2.3 27.8 ± 1.9 < 0.01*
Height (cm) 179.5 ± 3.7 171.8 ± 2.3 < 0.03*
Weight (kg) 82.5 ± 2.7 64.4 ± 2.9 < 0.01*
BMI (kg/m2) 25.5 ± 0.5 21.8 ± 0.7 < 0.01*
Resting heart rate (bpm) 63.1 ± 7.2 66.7 ± 11.3 0.41
Distance covered per week (km) 34.0 ± 9.0 38.7 ± 11.7 0.77
Endurance capability (self-rating,
1–10)
8.0 ± 0.8 6.4 ± 1.3 0.02*
FIN vs. NON
FIN NON p (FIN vs. NON)
n 11 21
Age (years) 35.7 ± 9, 7 34.3 ± 9.0 0.72
Height (cm) 180.5 ± 9.4 176.2 ± 8.2 0.18
Weight (kg) 72.36 ± 8.5 74.8 ± 12.7 0.58
BMI (kg/m2) 22.2 ± 1.3 23.9 ± 2.6 < 0.05§
Resting heart rate (bpm) 64.5 ± 9.2 64.6 ± 9.1 0.97
Distance covered per week (km) 55.4 ± 38.6 36.6 ± 29.7 0.18
Endurance capability (self-rating,
1–10)
7.6 ± 0.2 7.1 ± 0.3 0.32
Depicted are anthropometric data and subject demographics for male (m) and
female (f) subgroups in FIN and NON as well as a comparison between all subjects
of FIN and NON (presented are means ± SD).
∗Significant difference between male and female.
§Significant difference between FIN and NON.
slowest after 24.78 h. The fastest female completed the race
in 21.75 h and the slowest in 23.32 h. Mean speed was
4.12 ± 0.76 km/h in both sexes.
Subjects of FIN (4.39 ± 0.26 km/h) were faster compared
with subjects of NON (3.87 ± 0.98 km/h) as a trend (p = 0.19).
The subjects with the highest and lowest mean speed were both
subjects of NON, with a mean speed of 4.94 and 2.32 km/h,
respectively. FIN had a greater history of endurance training per
week as a trend (55.4 ± 38.6 vs. 36.6 ± 29.7 km; p = 0.18). Overall,
participants self-rated their endurance capability (mean) with a
7.3 out of 10 points; there were no significant differences between
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FIN and NON (7.6 ± 0.2 vs. 7.1 ± 0.3, p = 0.32), but male subjects
in NON-self-rated their endurance capability significantly higher
than female subjects (8.0 ± 0.8 vs. 6.4 ± 1.3, p = 0.02).
Body Composition
Participants reaching the 70-km checkpoint or the 100-km finish
were included in this analysis (n = 18, 9 female, 9 male), and one
participant who delivered faulty data was ruled out.
Pre-event mean body weight was 70.4 ± 10.3 kg with a mean
BMI of 22.4 ± 2.0 kg/m2. Both weight and BMI decreased
significantly post-event to 69.7 ± 10.2 kg (mean 1 = 0.7 kg;
p < 0.01) and 22.1 ± 2.0 kg/m2 (p < 0.01), respectively. BIA
testing revealed significant changes: lean body mass decreased
from 57.1 ± 10.5 to 56.2 ± 10.3 kg (p< 0.01) that correlated with
a loss in total body water (42.1 ± 8.5 L before vs. 41.3 ± 8.1 L after
MM; p < 0.01) (Mayer-Davis and Costacou, 2001). According to
the fat-specific formula (male < 20%; female < 30% body fat) of
Segal et al., this represents a loss of approximately 1.6% (0.9 kg)
and 1.9% (0.8 L), respectively. The percentage of body fat did not
change significantly (Table 2).
Serum Analysis
Serum parameter of FIN and NON-are depicted in
Supplementary Table 3.
Cardiac and Skeletal Muscle Cell Markers
In both groups, serum levels of NT-pro-BNP, CK, and CK-
MB increased significantly over the course of the MM. There
were no significant differences for means at certain checkpoints
between NON-and FIN (Figures 1A–C). Interestingly, mixed-
effects ANOVA for troponin T showed significant results, driven
by a significant increase only at the 30-km checkpoint (p < 0.05),
but not at 70 and 100 km (Figure 1B).
Fat Metabolism
Triglycerides decreased significantly over the duration of the
MM by over 50% (Figure 2A) in NON-and in FIN as a strong
trend (p < 0.06). LDL decreased by approximately 20% as
a strong trend in FIN (p = 0.05) (Figure 2B), while HDL
increased significantly in NON (Supplementary Table 1). Paired
t-tests showed a significant decrease after 70 km for cholesterol,
TABLE 2 | Body composition pre- and post-race.
Body composition
Pre Post p (pre vs. post)
n 18 18
Body mass (kg) 70.4 ± 10.3 69.7 ± 10.2 < 0.01*
BMI (kg/m2) 22.4 ± 2.0 22.1 ± 2.0 < 0.01*
Lean body mass (kg) 57.1 ± 10.5 56.2 ± 10.3 < 0.01*
Fat mass (kg) 13.3 ± 3.1 13.4 ± 2.9 0.66
Total body water (L) 42.1 ± 8.5 41.3 ± 8.1 < 0.01*
Presented are parameters of body composition in all participants that reached the
70- or 100-km checkpoint.
*Significant differences pre- to post-race.
LDL, and triglycerides as well as a significant HDL increment
(p < 0.05 for all).
Stress and Inflammatory Markers
C-reactive protein increased significantly over the course of the
MM in both groups starting at 70 km (Figure 3A). Cortisol
levels also changed significantly in both groups (Figure 3B). Of
interest, at 30 km, the cortisol level in NON-was significantly
higher than that in FIN, since the cortisol level initially declined
in the FIN group.
Sodium Alterations
Sodium levels declined in both FIN and NON-groups, while a
stronger decrease was observed in the FIN group up to 70 km
distance (Figure 4).
Correlation Analysis
Metabolic Equivalent of Task
Out of the 20 participants wearing actimeter armbands, 15
delivered usable serum samples (n = 15) for correlation analysis
[7 out of 11 finishing participants (FIN) and 8 of 21 non-finishers
(NON)]. From those participants, serum samples were gathered
for correlation analysis. Mean MET did not differ significantly
between groups or sex (Supplementary Table 2).
Data from the SenseWear armbands showed that participants
had a higher MET in the first quarter of the race (18:00–24:00)
in comparison to the last three quarters: mean MET from 18:00
to 24:00 h was 5.2, and from 24:00 to 18:00 h the next day, 4.4
(p < 0.01). Five MET was chosen as a cut-off value for a most
even distribution. Participants who exhibited a higher mean MET
(MET > 5) finished the track in a shorter time and walked with
a higher speed as a trend [3.95 ± 0.89 vs. 4.36 ± 0.47 km/h
(p = 0.32)]. Mean MET for subjects with a mean MET < 5 was
4.54 ± 0.31; for MET > 5, it was 5.25 ± 0.18.
Participants with mean MET < 5 showed a significantly higher
slope (= higher increase) for NT-pro-BNP (Figure 5) and CK-
MB in FIN. In NON, CK increased significantly greater for
participants with lower mean MET (Supplementary Table 3).
Our data indicate that NT-pro-BNP increased stronger in
non-finishing participants (NON). The slope for NT-pro-BNP
was significantly greater in NON-for participants that walked
with a mean MET > 5 than in FIN (Table 3).
Speed
Concerning speed, participants were divided into two subgroups:
mean speed >4.3 km/h (mean: 4.65 ± 0.15 km/h) and <4.3 km/h
(mean: 3.65 ± 0.72 km/h); 4.3 km/h was chosen as cut-off for a
most even distribution. Mean speed in FIN (4.39 ± 0.26 km/h)
was greater as a trend than in NON (3.87 ± 0.98 km/h;
p = 0.19). There were no significant differences regarding sex,
neither in FIN nor NON.
Slower participants had significantly higher cholesterol and
triglyceride levels in FIN (Figures 6A,B). CRP increased
significantly greater in slower participants in NON (Figure 6C).
CK levels were significantly greater in FIN for faster subjects,
as opposed to NON, where slower participants expressed a
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FIGURE 1 | NT-pro-BNP (A), troponin T (B), and creatine kinase (CK) (C) alterations in finishers (FIN) and non-finishers (NON). Boxes represent 25th to 75th
percentile, and whiskers minimum to maximum. Horizontal line shows median, and + shows mean. *Shows significant alterations to the previous checkpoint (paired
t-tests, p < 0.05).
greater increase of CK (Figure 6D). Exact values are presented
in Supplementary Table 4.
In the subgroup of faster participants > 4.3 km/h, finishers
showed a significantly greater increment of CK than non-
finishers (slope FIN: 13.9 ± 2.0; slope NON: 3.9 ± 1.3; p < 0.01).
In participants with a mean speed <4.3 km/h, NON-had
significantly greater CK levels (elevation) with a similar slope to
FIN (elevation FIN: 21.0 ± 89.2; elevation NON: 169.5 ± 66.1;
p = 0.04).
For all the other parameters, there were no significant changes,
or linear regression was not a fitting model.
Age
Mean age in FIN was 35.7 ± 9.7 years; in NON, it was
34.3 ± 9.0 years, so 35 years was chosen as the cut-off for a most
even distribution, in order to test for an age-related effect. Mean
age for participants older than 35 years was 41.6 ± 6.2 years; for
participants younger than 35, it was 27.9 ± 5.4. Linear regression
analysis showed significant differences for an increase in CK and
for a decrease in sodium (Supplementary Table 5). In FIN, older
participants showed a significant greater increase for CK values.
Sodium decreased significantly more in younger subjects in FIN.
In NON, younger subjects had a significantly lower elevation in
sodium (Figure 7).
For all the other parameters tested, there were no significant
changes, or linear regression was not a fitting model.
BMI
Concerning BMI, 23 kg/m2 was chosen as cut-off for a most
even distribution. Mean BMI in the group > 23 kg/m2
was 25.4 ± 2.0 kg/m2; in the group < 23 kg/m2, it
was 21.4 ± 1.3 kg/m2. Linear regression analysis showed a
significantly higher increase for CK, CK-MB, and AST for
participants with a higher BMI in FIN (p < 0.01) (Figure 8A).
In NON, participants with higher BMI showed significantly
higher elevations of LDL and lower HDL levels. Slopes did not
FIGURE 2 | Triglyceride (A) and LDL (B) alterations in FIN and NON. Boxes
represent 25th to 75th percentile, and whiskers minimum to maximum.
Horizontal line shows median, and + shows mean. *Shows significant
alterations to the previous checkpoint (paired t-tests, p < 0.05).
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FIGURE 3 | C-reactive protein (CRP) (A) and cortisol (B) alterations in FIN and
NON. Boxes represent 25th to 75th percentile, and whiskers minimum to
maximum. Horizontal line shows median, and + shows mean. *Shows
significant alterations to the previous checkpoint (paired t-tests, p < 0.05).
FIGURE 4 | Sodium alterations in FIN and NON. Boxes represent 25th to 75th
percentile, and whiskers minimum to maximum. Horizontal line shows
median, and + shows mean. *Shows significant alterations to the previous
checkpoint (paired t-tests, p < 0.05).
differ significantly (Figures 8B,C). CRP increased stronger in
participants with a higher BMI as a trend in both FIN and
NON (p < 0.10) (Figure 8D). Exact values are presented in
Supplementary Table 6.
Sex
All serum parameters were analyzed with linear regression
analysis for significant differences in male and female. NT-pro-
BNP and HDL showed significantly higher elevations in females
of both FIN and NON-groups (Figures 9A,B). Baseline NT-
pro-BNP was significantly higher in females (54.20 ± 10.60
pg/ml) as confirmed by t-test (male: 25.9 ± 4.6 pg/ml; p = 0.01).
Supplementary Table 7 depicts the exact results.
FIGURE 5 | NT-pro-BNP over MET in FIN and NON. The black line represents
the regression line in FIN, and the gray line represents the regression line in
NON.
For all the other parameters, there were no significant changes,
or linear regression was not a fitting model.
Baseline NT-pro-BNP
It was also evaluated whether a higher baseline NT-pro-BNP > 30
pg/ml led to different changes in serum parameters than a lower
baseline NT-pro-BNP < 30 pg/ml with linear regression analysis.
NT-pro-BNP values for participants with higher baseline NT-
pro-BNP increased relatively stronger, shown by a significantly
higher slope in linear regression analysis in FIN (Supplementary
Table 8 and Figure 10).
In the subgroup of participants with a baseline NT-pro-
BNP < 30 pg/ml, subjects who were not able to finish the race
(NON) had a significantly greater increment of NT-pro-BNP
over the course of the MM, compared with FIN (slope NON:
1.37 ± 0.24; slope FIN: 0.30 ± 0.09; p < 0.01). In subjects with
a baseline NT-pro-BNP > 30 pg/ml, there were no significant
changes. Finally, heart rate did not differ significantly for groups
with regard to NT-pro-BNP.
Mean Heart Rate During the Race
All serum parameters were analyzed with linear regression
analysis for significant differences between participants that had
a mean heart rate <106.5 and >106.5 bpm during the race;
106.5 bpm was the median and chosen as the cut-off value. Mean
heart rate during the race in FIN was 106.8 ± 8.5 bpm; in NON,
it was 108.5 ± 13.4 bpm (p = 0.79).
In NON, NT-pro-BNP showed a significantly higher increase
in participants with a mean heart rate > 106.5 during the MM
(p = 0.02) (Figure 11A and Supplementary Table 9). Participants
with a greater heart rate during the MM > 106.5 bpm showed
significantly higher levels for troponin T (p = 0.02) and higher
levels for triglycerides as a trend (p = 0.11) (Figures 11B, 12B and
Supplementary Table 9). In FIN, participants with greater heart
rate during the race had significantly higher values of triglycerides
(p = 0.02), and troponin T levels were greater as a trend (p< 0.10)
(Figures 11B, 12B and Supplementary Table 9). In both FIN
and NON, subjects with lower heart rates during the race had
significantly higher elevations of HDL (p < 0.01 in FIN and
p = 0.02 in NON) (Figure 12A and Supplementary Table 9).
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TABLE 3 | NT-pro-BNP over MET subgroups dependent on outcome.
Linear regression MET < 5 MET > 5
FIN NON FIN NON
n 5 4 2 4
NT-pro-BNP r2 0.67 0.85 0.93 0.64
(pg/ml) Slope 1.30 ± 0.78 2.08 ± 0.33 0.21 ± 0.02 1.52 ± 0.40
Elevation 36.86 ± 15.21 17.60 ± 10.06 18.19 ± 1.45 17.63 ± 14.80
p (lines different?) Slope: 0.17 Elevation: 0.98 Slope: < 0.01 Elevation: n.c.
Presented are linear regression parameters for NT-pro-BNP in participants exercising with a mean MET > 5 and < 5 in FIN and NON. Presented are goodness of fit (r2),
slope ± SD, elevation ± SD, and p values for slope and elevation to determine whether regression lines are significantly different. NT-pro-BNP levels rise significantly
stronger in NON in the subgroup of MET > 5, shown by a significantly greater slope.
FIGURE 6 | Cholesterol (A), triglycerides (B), CRP (C), and CK (D) over speed in FIN and NON. The black line represents the regression line in FIN, and the gray line
represents the regression line in NON.
DISCUSSION
This study was conducted to evaluate whether a low-intensity
long-endurance march, during which participants were walking
instead of running or jogging, would elicit similar changes
in body composition, metabolism, and cardiovascular risk
markers as described previously in higher intensity marathons or
ultramarathons (Ginsburg et al., 1996; Fallon, 2001; Wu et al.,
2004; Scharhag et al., 2005, 2006; Knechtle et al., 2008a; Scott
et al., 2009; Kasprowicz et al., 2013; Kłapcińska et al., 2013;
Marklund et al., 2013; Kim et al., 2014; Salvagno et al., 2014; Vilela
et al., 2015; Baur et al., 2016; Emed et al., 2016; Yoon et al., 2016;
Coker et al., 2017). To our knowledge, this is the first investigation
to evaluate a broad range of physiological parameters among
healthy human adults in such a unique setting. Data from
actimeter armbands showed that the MM was conducted at a
lower mean speed (4.12 km/h) and therefore lower intensity
(mean MET ≈5) than in classical (ultra-) marathons, conducted
with jogging and running speeds of 8–14 km/h (Scharhag et al.,
2005; La Gerche et al., 2008) and a mean energy expenditure of
8–10 (Mendes et al., 2018); in addition, the average in-race heart
rate (≈106–108 bpm) was comparatively low.
The considerable amount of distances covered on foot per
week (≈35–55 km), a good self-evaluated endurance capacity
(≈7.3 out of 10) combined with the low-normal mean resting
heart rates (≈67 bpm) (Kannel et al., 1987), and a normal mean
BMI (≈22–25 kg/m2; Global Bmi Mortality Collaboration et al.,
2016) suggest that our study participants were aerobically fit and
healthy recreational athletes, but not highly trained endurance
athletes who display much lower resting heart rates of below
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FIGURE 7 | Sodium over speed in FIN and NON. The black line represents the
regression line in FIN, and the gray line represents the regression line in NON.
50 bpm (Doyen et al., 2019) and, in severe cases, even below
30 bpm (Jensen-Urstad et al., 1997).
It is a noteworthy finding that despite a greater amount of
distance covered on foot per week by the female subjects of our
study in both FIN and NON, the self-rated endurance capability
was lower as a trend among women compared with men in
FIN and differed significantly between men and women in NON
(8.0 ± 0.8 vs. 6.4 ± 1.3; p = 0.02). This supports previous
findings that women underestimate their capabilities in general
(Beyer, 1990) and their physical performance in particular
(Obling et al., 2015). Further research appears warranted with
regard to self-perceived gender differences among marathon and
ultramarathon runners.
We hypothesized that the low working intensity of the
evaluated “Mammutmarsch,” during which participants were
required to walk instead of running or jogging, would cause no
elevation of muscle and cardiac stress markers among our study
participants. However, measurements of several physiological
parameters as well as testing for the various serum stress markers
indicated that, opposite to our working hypothesis, significant
changes in stress parameters, such as CRP, CK, CK-MB, AST,
ALT, cortisol, and NT-pro-BNP, have occurred, as well as in
parameters of lipid metabolism (cholesterol, LDL, HDL, and
triglycerides). As further discussed below, we conclude that the
distance, intensity, and most importantly duration determine the
exertion and, thus, the physiological impact.
Body Composition and Hydration Status
As previously shown by other studies (Knechtle et al., 2008a; Baur
et al., 2016), we observed a significant decrease in total body
mass (−1%, p < 0.01) over the course of this low-intensity long-
endurance event. In contrast to the higher intensity multistage
ultramarathons described by Baur et al. (2016) and Knechtle et al.
(2008a), the weight loss in our study was caused by a loss of fat-
free mass (−1.6%, p < 0.01) and a decrease in total body water
(TBW; −1.9%, p< 0.01), respectively. In contrast, the mentioned
studies found a significant loss in fat mass [24.4% (Baur et al.,
2016) and 42.7% (Knechtle et al., 2008a)] with no significant
changes in TBW (Baur et al., 2016) and lean body mass or even
a significant increase in TBW (Knechtle et al., 2008a). Knechtle
et al. (2008b) described a correlation between intensity and loss
of body fat during the Triple Iron Triathlon Germany 2006 in
Lensahn. Participants with a better performance during the MM
showed a moderately larger decrease in fat mass. This effect is also
described in laboratory settings; in their study with 18 moderately
trained cyclists taking part in continuous prolonged exercise tests,
FIGURE 8 | CK (A), LDL (B), HDL (C), and CRP (D) over BMI in FIN and NON. The black line represents the regression line in FIN, and the gray line represents the
regression line in NON.
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FIGURE 9 | NT-pro-BNP (A) and HDL (B) over sex in FIN and NON. The black
line represents the regression line in FIN, and the gray line represents the
regression line in NON.
Achten et al. (2002) found that with higher intensity, there is an
increase in fat oxidation, up to a maximum fat oxidation rate at
an intensity of 64 ± 4% of VO2max. Nevertheless, Coker et al.
(2017) described that during the Yukon Arctic Ultramarathon,
which also takes place at lower intensities, in this case with
an average speed of 2–3 mph (corresponding to 3.2–4.8 km/h),
fat loss occurred. It should be mentioned that in this setting
participants marched up to 430 miles (≈690 km) in 7–14 days
in adverse climate conditions with temperatures reaching down
to −45◦C. Thus, participants suffered from exercise-induced
caloric expenditure for a much longer period of time, with
chronic exposure to extreme cold as an additional burden. Also
in the studies of Baur et al. (2016) and Knechtle et al. (2008a),
participants exercised 30 to more than 48 h in two to three
consecutive days. Alpert (2005) described 290 kJ/kg per day the
maximal transfer rate of energy from FM. With a mean FM of
approximately 13.3 kg in this study, this results in a maximal
possible fat loss of roughly 120 g, assuming 7,700 kcal (about
32,000 kJ) is needed to burn 1 kg of body fat (Wishnofsky, 1958).
Thus, most likely the maximum duration of 24 h was not enough
to exhibit a significant loss of FM, regardless of the intensity. But
even under these extreme settings, several studies reported high
levels of muscle preservation (Knechtle et al., 2008a; Saugy et al.,
2013; Coker et al., 2017).
From the fact that the loss of body mass in our study is
mainly a loss of TBW, associated with muscle preservation in
even more extreme settings (Knechtle et al., 2008a; Saugy et al.,
FIGURE 10 | NT-pro-BNP over baseline NT-pro-BNP in FIN and NON. The
black line represents the regression line in FIN, and the gray line represents
the regression line in NON.
2013; Coker et al., 2017), we conclude that a loss of body
mass is most likely a consequence of sweating in connection
with insufficient rehydration. This assumption is supported by
our data showing a decrease in serum sodium levels over
the course of the MM that resulted in a mild hyponatremia
in six participants (minimum: 131 mmol/L). This could be
interpreted as a consequence of dehydration and rehydration
with large amounts of fluids, resulting in dilution hyponatremia
(Knechtle and Nikolaidis, 2018).
Nevertheless, sodium levels reached no critical values,
implying adequate rehydration. Supportingly, Noakes
et al. (2005) described a loss of body mass < 3% as a
status of euhydration.
Linear regression analysis showed that younger participants
had a stronger decrease of sodium. A possible explanation for
this might be training status. In their review, Knechtle and
Nikolaidis (Knechtle and Nikolaidis, 2018) suggested an age of
30–50 to be the “best” years to take part in an ultramarathon.
The longer the distance, the better the achievements of the
older participants were (Knechtle et al., 2014). This implies
adaptation to long-term training (Knechtle and Nikolaidis, 2018).
Additionally, it is scientific consensus that aging reduces the
sensitivity of sweat glands to acetylcholine, leading to a reduced
sudomotor function (Lee et al., 2016). Therefore, by sweating
more, younger participants might have lost more sodium than
older participants. Furthermore, it is widely accepted that older
subjects feel less thirst and therefore drink later (Arai et al.,
2014). Thus, we speculate that there was less sodium loss and
blood dilution, explaining the relatively higher sodium levels in
older participants.
NT-pro-BNP
Synthesis of NT-pro-BNP is triggered mechanically by ventricle
stretching and neurohumoral stimulation (Nakagawa et al.,
1995). Among other cardiac stress markers, NT-pro-BNP
increased significantly in every single participant. Over the course
of the march, there was almost a fourfold increment from 37.4
to 142.2 pg/ml. Notably, NT-pro-BNP values of > 125 pg/ml
can indicate acute congestive heart failure (Maisel et al., 2002;
Cowie et al., 2003).
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FIGURE 11 | NT-pro-BNP (A) and troponin T (B) over mean heart rate during
the race in FIN and NON. The black line represents the regression line in FIN,
and the gray line represents the regression line in NON.
Elevation of NT-pro-BNP after and during long-endurance
events as a cardiac stress parameter is well described in several
studies (Scharhag et al., 2005; Scott et al., 2009; Banfi et al.,
2012; Kłapcińska et al., 2013; Kim et al., 2014; Salvagno et al.,
2014). In a 48-h run with a mean distance of 170 km, NT-
pro-BNP increased 10-fold in the first 24 h from 54 to 508
pg/ml (Kłapcińska et al., 2013). In male athletes, Scharhag et al.
described a threefold increase (40–130 pg/ml) after a marathon, a
sixfold increase (40–250 pg/ml) in a 100-km ultramarathon, and
a fourfold increase (20–80 pg/ml) in a 110-km mountain bike
marathon (Scharhag et al., 2005). These events were running or
biking events; therefore, intensity levels were higher, compared
with our study. In a longer low-intensity 308-km run, Yoon et al.
(2016) reported an almost 10-fold increase (27–257 pg/ml).
It is one of the main findings of our study that also a low-
intensity long-endurance march like the MM leads to changes
in NT-pro-BNP levels comparable to higher intensity long-
endurance running events. Currently, the majority of studies
(Scharhag et al., 2005, 2008; Banfi et al., 2012; Kłapcińska
et al., 2013) interpret increasing NT-pro-BNP levels as part
of a process of myocardial adaption rather than a harmful
effect (La Gerche et al., 2008). Moreover, recent studies
described that the duration of the exercise might have a higher
influence on NT-pro-BNP levels than exercise intensity (Legaz-
Arrese et al., 2011; Serrano-Ostáriz et al., 2011). Comparing
our study to longer low-intensity endurance events, showing
a greater NT-pro-BNP increment, our data supports this
hypothesis (Kłapcińska et al., 2013; Yoon et al., 2016). A possible
explanation for this phenomenon was given by Legaz-Arrese
FIGURE 12 | High-density lipoprotein (A) and triglycerides (B) over mean
heart rate during the race in FIN and NON. The black line represents the
regression line in FIN, and the gray line represents the regression line in NON.
et al.: NT-pro-BNP release is triggered by ventricle stretching
and therefore preload changes. Higher intensities result in higher
heart rates and shorter R-R intervals, so preload stretch is limited
and intensity and preload do not increase in a linear fashion
(Nakagawa et al., 1995; Legaz-Arrese et al., 2011). However,
the aforementioned studies were conducted at much higher
intensities at above 85% of their participant’s anaerobic threshold
(Legaz-Arrese et al., 2011; Serrano-Ostáriz et al., 2011).
Interestingly, participants who could only sustain a lower
mean MET showed a greater increment of NT-pro-BNP.
Furthermore, in the subgroup of participants exercising with a
mean MET > 5, non-finishing participants showed significantly
stronger increasing NT-pro-BNP values. This raises the question
whether NT-pro-BNP might be a marker for cardiovascular
capacity also in healthy adults. Our data indicate that NT-pro-
BNP values increased stronger in participants with higher heart
rates during the race (>106.5 bpm) in NON, underpinning this
theory, as heart rate is inversely correlated with cardiorespiratory
fitness (Kang et al., 2017). Moreover, recent studies showed
that higher NT-pro-BNP levels were associated with lower
cardiorespiratory fitness in patients with chronic heart disease
(Nichols et al., 2018). Scharhag et al. (2006) found a similar
result with a negative correlation between the increase in NT-
pro-BNP and the amount of endurance training per week
in healthy athletes: participants with higher training volumes
showed lower increases in NT-pro-BNP, one given explanation
was a better adapted myocardium on endurance exercise bouts.
A greater increment for NT-pro-BNP in participants with higher
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baseline NT-pro-BNP values observed in finishing participants
of this study supports this hypothesis. All in all, our data
suggest that even at low intensities as observed in our study,
NT-pro-BNP increases take place among healthy adults that
might indicate a cardiac stimulation and may thus represent
possible cardiac training previously seen only at higher intensities
(Vilela et al., 2015). Nevertheless, to gain unambiguous data,
further studies are needed, as, e.g., the subgroup of participants
with a lower mean MET did not show significant differences
between FIN and NON.
Troponin T
Exercise-induced troponin elevations after prolonged physical
activity have been described in several studies (Scharhag et al.,
2005, 2006, 2008; Scott et al., 2009; Eijsvogels et al., 2010; Legaz-
Arrese et al., 2011; Serrano-Ostáriz et al., 2011; Banfi et al.,
2012; Kłapcińska et al., 2013; Kim et al., 2014; Salvagno et al.,
2014; Arakawa et al., 2016; Yoon et al., 2016; Knechtle and
Nikolaidis, 2018). The clinical significance is still debated. While
some authors postulate exercise-induced irreversible myocardial
injury, cell necrosis, or damage (Koller et al., 1999; Eijsvogels
et al., 2010), others presume a reversible release of cytoplasmic
troponins due to membrane leakage or changes in intracellular
calcium levels without any pathological consequence (Scharhag
et al., 2005, 2008; Shave et al., 2007; Benda et al., 2016).
Interestingly, some studies on ultramarathons indicated no
increase of troponin T (Kim et al., 2014). In this study, we
observed a significant elevation of troponin T after the 30-
km distance but found normal levels at the 70- and 100-km
checkpoints. A similar troponin dynamic was found in a 48-
h ultramarathon (Kłapcińska et al., 2013). This might show
an adaption process to the prolonged myocardial and volume
stress. Another possible explanation might be the impact of
intensity. The activity data suggests that participants started with
a significantly higher mean MET in the first third of the race
possibly leading to troponin T elevation. Similar observations
were made in the 48-h ultramarathon, in that subjects ran with a
higher mean speed in the first 12 h (8.6 km/h) compared with the
next 12 h (6.0 km/h) (Kłapcińska et al., 2013). With exhaustion-
induced lowering of walking or running speed in the last two
thirds of the race, intensity might be below the exertion level
causing troponin T excretion.
This conclusion is supported by Scharhag et al. (2005).
They compared a marathon, mountain bike marathon, and
a 100-km ultramarathon. Median troponin T concentrations
increased significantly during the marathon and the mountain
bike marathon only, but not during the lower intensity
100-km ultramarathon. Supporting this theory, Shave et al.
(2007) suggested a cardiac troponin correlation to intensity, as
shown in their meta-analysis, where athletes in shorter long-
endurance events, such as marathons, expressed the highest
troponin elevations.
Our study supports the hypothesis of an intensity-related
release of cardiac troponins. Furthermore, greater troponin T
elevations in subjects with higher heart rate during the race
support the findings of Mehta et al. of an inverse correlation to
training status (Mehta et al., 2012). Further studies are warranted
to gain more understanding into the release of cardiac troponins
and exercise intensity and duration.
Markers for Cell Damage
Aminotransferase, CK, and CK-MB are muscle cell enzymes,
released by the breakdown of skeletal muscle (Khan, 2009).
For all, levels increased significantly over the course of the
MM. CK reached levels more than 10 times above the URL,
which indicates severe muscular damage. CK-MB and AST
increased fourfold and threefold, respectively. A generally
accepted explanation is cell leakage due to mechanical tissue
damage (Kłapcińska et al., 2013).
Increases of muscle stress markers after long-endurance
exercise were described in several studies (Scharhag et al., 2005;
Banfi et al., 2012; Waśkiewicz et al., 2012; Kłapcińska et al., 2013;
Kim et al., 2014; Arakawa et al., 2016; Baur et al., 2016; Yoon
et al., 2016; Knechtle and Nikolaidis, 2018). Training status, sex,
duration, BMI, age, and intensity are considered as an impact
factor for interindividual CK elevation (Neal et al., 2009; Banfi
et al., 2012; Waśkiewicz et al., 2012; Kłapcińska et al., 2013; Yoon
et al., 2016; Kim and So, 2018; Nichols et al., 2018).
In our study, CK and CK-MB levels increased continuously
over distance, reaching its maximum level at 100 km or the
individual point of dropping out of the MM. Studies covering
ultramarathons observed a strong variance in CK levels: Scharhag
et al. (2005) and Yoon et al. (2016) described relatively moderate
CK elevations after a marathon and 100 km ultramarathon,
although participants ran with a higher running speed (around
10 km/h). In contrast, in a 308-km ultramarathon, CK levels
reached 5,270.06 U/L, an almost 35-fold increment (Yoon et al.,
2016). Waśkiewicz et al. (2012) described CK elevations up to
17,500 U/L in a 24-h ultramarathon with a mean speed of 7 km/h.
Such large CK elevations were also observed by Kłapcińska et al.
(2013) after running 24 h with a mean speed of 7.3 km/h,
reaching 18,000 U/L. It is worth mentioning that in the studies
of Kłapcińska et al. (2013) and Waśkiewicz et al. (2012), amateur
runners were tested, while Scharhag et al. (2005) and Yoon et al.
(2016) assessed experienced endurance athletes. In our study,
recreational athletes were recruited and CK increased to a greater
degree in all participants with a mean MET < 5. Strikingly, this
contradicts the view of intensity being the relevant impact factor.
Nevertheless, it can be argued that athletes who were only able
to walk with a lower mean MET are possibly less trained and
therefore training status has the major impact (Banfi et al., 2012).
We observed that age, BMI, and sex impact CK elevation
in the low-intensity MM. Older participants with a higher BMI
and males compared with females showed higher CK elevations.
Males had a higher BMI in this study, so there might be a
confounding effect. Nevertheless, higher BMI is described as an
impact factor for CK elevation (Neal et al., 2009; Banfi et al.,
2012; Kim and So, 2018). For age as an impact factor, variable
results exist. As assessed in a review (Baird et al., 2012), some
authors describe age as a factor contributing to greater exercise-
induced damage, and others report lower CK elevations, pointing
to age-related sarcopenia as a cause.
Aminotransferase is generally accepted as a marker for
skeletal muscle cell damage after long-endurance exercise
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(Banfi et al., 2012; Waśkiewicz et al., 2012; Kłapcińska et al.,
2013). On average, AST increased approximately 2.5-fold, while
ALT increased only marginally. In this study, increases of AST
are interpreted as a marker for skeletal muscle cell damage and
not liver cell damage, as also suggested by other studies (Banfi
et al., 2012; Waśkiewicz et al., 2012; Kłapcińska et al., 2013). In
our cohort, AST levels were further associated with higher age, as
well as higher BMI, which supports data previously reported in
the literature (Banfi et al., 2012).
Like CK, CK-MB is also known as a marker for muscle cell
damage, in skeletal muscles as well as in the myocardium (Kim
et al., 2014; Yoon et al., 2016; Knechtle and Nikolaidis, 2018). As
it is also a marker for myocardial cell damage, it is to be discussed
whether CK-MB increment in this setting is also representative
for cardiac injury. Over the course of the race, mean CK-MB rose
approximately 4.5-fold, while CK levels increased almost 10-fold.
Studies suggested that the considerably CK increases represented
predominantly a skeletal muscle damage also because in the
abovementioned studies no cardiac injury was reported (Kim
et al., 2014; Knechtle and Nikolaidis, 2018). Normal troponin T
levels at 70 and 100 km support the hypothesis of skeletal muscle
damage instead of cardiac cell damage or even necrosis.
Stress Parameters
C-reactive protein increased significantly by the end of the MM
and reached values 25 times higher than the baseline. After
70 km, CRP increased from 1–2 to 7 mg/L, reaching 25 mg/L
after 100 km. CRP elevation as acute phase response marker
after long-endurance exercise has been described by multiple
other studies (Fallon, 2001; Waśkiewicz et al., 2012; Kasprowicz
et al., 2013; Kłapcińska et al., 2013; Baur et al., 2016). IL-6 is
widely described as the inducing element of CRP production in
the liver, which plays an anti-inflammatory role (induction of
anti-inflammatory cytokines) and targets and induces removal of
damaged cells (Waśkiewicz et al., 2012; Kłapcińska et al., 2013).
Duration and intensity are the main factors in CRP elevation
(Waśkiewicz et al., 2012; Kłapcińska et al., 2013). In a 3-day
multistage ultra-endurance triathlon in which subjects exercised
for a total of roughly 30 h with resting periods in between
the stages, CRP increased from <1 to 9 mg/L (Baur et al.,
2016). Untrained subjects in the study of Kłapcińska et al. (2013)
showed an increment from <1 to 30 mg/L after running for
24 h with a mean speed of roughly 7.3 km/h. Fallon (2001)
observed similar dynamics in a track race: CRP increased from
1.9 to 21.9 mg/L after 24 h, covering a distance of 142.6 km/h.
The greatest increment was found in a 24-h ultramarathon in
which subjects ran with a mean speed of 7 km/h: CRP pre-
race was 1.7 mg/L, 8.7 mg/L after 12 h, and reached 39.2 mg/L
after 24 h (Waśkiewicz et al., 2012). All subjects in the cited
studies ran with a higher running speed than those in this study.
Nevertheless, CRP increased in a comparable fashion in this
low-intensity march.
Cortisol showed a significant dynamic over the course of
the march. Changing cortisol levels can be interpreted as
part of its physiological circadian rhythm (Edwards et al.,
2001) as serum samples have been taken over the course
of 24 h. Nevertheless, values after 70 km distance of the
MM reached levels that are outside the URL, showing a
neuroendocrine answer to this long-endurance low-intensity
event. Studies describe cortisol elevations as a response to stress
through physical exercise, inducing a neuroendocrine answer,
which is necessary to conserve energy for vital functions (by
suppression of the hypothalamo–pituitary–gonadal axis) and to
increase substrate availability (cortisol-induced gluconeogenesis)
(Popovic et al., 2019).
Lipid Profile
Triglyceride serum concentrations decreased significantly over
the course of the MM in FIN and NON. Cholesterol and
LDL decreased significantly in FIN. Notably, the mixed-effects
ANOVA showed only nearly significant results, as cholesterol
and LDL levels decreased to a large extent only after 70 km.
Triglyceride levels (baseline: 1.27–1.33 mmol/L) started to
decrease already after 30 km (1.05 mmol/L) and reached
0.59 mmol/L after 100 km. Paired t-tests showed that LDL
and cholesterol significantly decreased from 70 to 100 km,
dropping by roughly 20% and approximately 12%, respectively.
Additionally, HDL levels (baseline: 1.61 mmol/L) increased
significantly at 70 km (2.05 mmol/L) in NON, and the increment
in FIN started only after 70 km rising to 1.86 mmol/L post-march.
Favorable shifts in blood lipid levels during ultramarathons are
well established in the literature (Ginsburg et al., 1996; Wu et al.,
2004; Banfi et al., 2012; Waśkiewicz et al., 2012; Emed et al.,
2016; Knechtle and Nikolaidis, 2018). We found that females
showed higher elevations of HDL, corroborating the findings in
the current literature (Davis et al., 1996).
In the higher intensity Hawaii Ironman Triathlon in which
athletes exercised for a total of approximately 12.5 h, Ginsburg
et al. (1996) observed a 9% decrease of cholesterol, a 39%
decrease of triglyceride levels, and a 10% decrease of LDL.
HDL did not change significantly. In a 24-h ultramarathon,
in which participants ran with a mean speed of 7 km/h for
almost 170 km, cholesterol decreased from 5.07 to 4.04 mmol/L,
LDL from 2.86 to 1.74 mmol/L, and triglycerides from 1.73 to
0.80 mmol/L, and HDL increased from 1.43 to 2.01 mmol/L
(Waśkiewicz et al., 2012).
Notably, the lipid profile changes in our study were
comparable to triathlons or ultramarathons of much
higher intensities.
Long-endurance events like ultramarathons cause a high
caloric demand, and carbohydrates as a source of energy
have limited stores in the body (Coyle et al., 1986). Hence,
an increase of fat oxidation, resulting in the mobilization
of storage fat, is needed to cover the energy expenditure
(Waśkiewicz et al., 2012; Kłapcińska et al., 2013). Since blood
lipid profile with high cholesterol levels is established as a main
risk factor for chronic heart disease, it can be argued that
long-endurance exercise should be considered beneficial for the
prevention of cardiovascular diseases (Knechtle and Nikolaidis,
2018). Aadahl et al. (2007) described a linear correlation between
moderate physical activity and cardiovascular risk factors. Mann
et al. (2014) also described a linear dose–response relationship
between activity levels and HDL cholesterol levels. To reduce
LDL and triglyceride levels, higher intensities have been reported
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to be required (Mann et al., 2014). Especially aerobic exercise
at high intensities is reported to be effective in improving the
LDL/HDL ratio (Mann et al., 2014). Fikenzer et al. (2018) even
mentioned a minimum exercise threshold to produce beneficial
effects on serum lipids. In contrast, however, a decrement in
cholesterol and LDL levels was also observed after 70 km in this
long-endurance low-intensity setting, suggesting that a constant
low-intensity activity such as during the MM might be as effective
as an influence on lipid profiles as shorter high-intensity exercises
that have been previously reported.
Nevertheless, even in this 100-km march of low-intensity,
participants who walked with greater speed showed more
favorable lipid profiles than slower participants. A possible
explanation could be a better training status in faster individuals,
resulting in a higher mean walking speed, as endurance training
is considered beneficial for lipid status (Knechtle and Nikolaidis,
2018), but also due to a higher rate of fat oxidation found among
better trained endurance athletes (Bassett and Howley, 2000).
Also in this study, FIN had a greater history of endurance training
as distance covered on foot per week as a trend. In addition, the
less favorable triglyceride levels among subjects with greater heart
rate and the more favorable HDL levels in participants with lower
heart rate during the race support this explanation. The fact that
participants of FIN walked with a greater walking speed as a trend
(4.39 vs. 3.79 km/h, p = 0.19) adds to this as well.
This study also showed the expected correlation between
greater BMI and higher plasma lipid levels (Waśkiewicz et al.,
2012). Eijsvogels and Maessen (2017) described striking risk
reductions for all-cause and cardiovascular mortality already at
low volumes of physical activity, with additional health benefits
with increasing exercise volumes. Especially for subjects with a
higher BMI or cardiac disabilities who are not able to train with
higher intensities, low-intensity but longer endurance exercise
might lead to benefits. In conclusion, our study coincides with
clinical trials, suggesting health benefits concerning the lipid
profile from low-intensity long-endurance exercise.
General Remarks and Limitations
Even though this study showed highly significant results, the
low number of participants limits the validity, especially in FIN
and in correlation analyses of subgroups. In some cases, FIN
and NON-did not show the same results or did not reach
the same level of significance. This might be due to the low
number of participants and lower statistical power of FIN.
Nevertheless, the overall number of 43 participants (32 with
usable serum samples) in that kind of experimental setting in a
field study conducted over 3 years in our investigation is relatively
high, as most studies assessing ultramarathons covered 5–35
participants (Fallon, 2001; Wu et al., 2004; Scharhag et al., 2005;
Knechtle et al., 2008a,b; La Gerche et al., 2008; Scott et al., 2009;
Waśkiewicz et al., 2012; Kasprowicz et al., 2013; Kłapcińska et al.,
2013; Marklund et al., 2013; Saugy et al., 2013; Kim et al., 2014;
Salvagno et al., 2014; Baur et al., 2016; Emed et al., 2016; Yoon
et al., 2016; Coker et al., 2017). The differentiation into FIN
and NON, even though numbers in those subgroups were small,
allowed us to perform a differential analysis of performance to
detect possible influencing factors.
A different training status among subjects needs to be
considered as a potential influencing factor as well. Even though
subjects of FIN did not exhibit a statistically significant greater
amount of distance covered per week, our assessment points in
that direction as a trend.
Another influencing factor might be each participant’s
nutrition or hydration plan, which was not assessed. This could
have had an influence on blood parameters. To minimize the
influence, participants were instructed to neither eat nor drink
at least 1 h before each checkpoint.
Both speed and MET were used for correlation analysis, as no
linear correlation was to be expected because of the individuals’
heterogenic conditions. A well-trained participant with low BMI
can express a lower mean MET and still walk faster than an
untrained, heavier person and vice versa. The different results in
these analyses confirm this assumption.
Furthermore, we would like to point out that data was
acquired over 3 years in three different MM events. Nevertheless,
weather and GPS data show that these races took place under
similar conditions, and consequently, we consider the acquired
data as comparable.
Serum samples were stored for up to 24 h in a sealed
cooling box before further processing. The analyzed parameters
should not be affected by this; nevertheless, some serum
samples were not usable due to hemolysis, thereby reducing the
statistical power.
Summary
Despite the low walking speed and hence low intensity, at
which the MM was conducted, our data reveal significant
changes among healthy human adults in body composition,
metabolism, and stress parameters that were comparable to
those observed in ultramarathons of much higher intensity and
different kind of athletes. Participants lost around 1% of body
mass, mostly from a significant loss of body water (-1.9%),
while the duration of 24 h was not long enough to reduce fat
mass significantly.
NT-pro-BNP showed a significant elevation over time and
distance, indicating that even at such low intensities a sufficient
cardiac stimulation might have taken place. The duration of
low-intensity activity turned out to be the main impact factor.
Despite reaching values above the URL, no evidence for cardiac
cell damage was found, as troponin T values increased only
moderately in the first third of the race, later returning to
baseline values. Other than for NT-pro-BNP, intensity seemed
to have been the predominant factor for exercise-induced
troponin T release. As performance and heart rate during
the race correlated with the increment of NT-pro-BNP values,
NT-pro-BNP might be a marker for cardiovascular fitness also
in healthy individuals. Training status seems to have correlated
with cardiac stress markers as well. Further studies are needed to
confirm this hypothesis.
In addition, this low-intensity march elicited massive
changes in markers for cell damage, showing skeletal muscle
damage leading to an acute inflammatory response. Current
literature suggests a quick cell repair and return to baseline
values after exercise.
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The MM triggered shifts to a favorable lipid profile
comparable to endurance events of much higher intensity. Also,
for cholesterol, duration seems to have the greatest influence,
as LDL and cholesterol started to decrease significantly only
after 70 km. It is a clinically relevant finding that a low-
intensity exercise can have an impact on serum lipids, as subjects
with pre-existing conditions might not be able to exercise at
higher intensities.
In addition, even though none of our participants were
professional endurance athletes, our results suggest that a more
active lifestyle, as the trend-wise greater distance covered on foot
per week among FIN, will lead to a more favorable lipid profile
and better performance.
In conclusion, long-endurance marches like the 100-km MM
can lead to striking increases in stress metabolism markers.
Thus, such long-duration events could not be recommended
for the general population to improve cardiovascular fitness.
Nevertheless, in the light of increasing prevalence of metabolic
diseases associated with a sedentary lifestyle (Arocha Rodulfo,
2019), which can be construed to be a negative environmental
factor on the health of a large proportion of the population
in western societies (Lin et al., 2020), the results of our study
might help to bring about health benefits by changing the lifestyle
from a sedentary to a more active one (e.g., walking instead of
driving, using the stairs instead of the elevator, etc.). Since our
data suggest that even exercise at low intensities such as walking
can have the reported positive benefits, our study supports several
recommendations already incorporated in general guidelines
(Anton et al., 2011) and could further help clinicians apply
lifestyle changes for the health benefits of their patients.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The study was approved by the Charité Ethics Board
(review number EA1/163/14). Written informed consent to
participate in this study was provided by the participants’ legal
guardian/next of kin.
AUTHOR CONTRIBUTIONS
MJ contributed in writing the manuscript, performed the
measurements, and obtained and analyzed the data. MS
designed, planned and implemented the study, performed the
measurements, and obtained the data. HG and MS provided
the critical expertise, feedback, and revised the final manuscript.
All authors contributed to the article and approved the
submitted version.
FUNDING
The study was supported by the Bundesministerium für
Wirtschaft und Energie (BMWi) and the German Aerospace
Center (DLR) through grants 50WB1330 and 50WB1730. The
Open Access Publication Fund of Charité – Universitätsmedizin
Berlin has been funding the publication fees.
ACKNOWLEDGMENTS
We would like to express our deepest gratitude to each athlete
participating in this study, as well as the race organizers. We also
acknowledge and are grateful for the support from the German
Research Foundation (DFG), the Open Access Publication Fund
of Charité Universitätsmedizin Berlin, as well as the Federdal
Ministry For Economic Affairs and Energy (BMWi), and the
German Aerospace Center (DLR), all of which made this
study possible.
SUPPLEMENTARY MATERIAL




Aadahl, M., Kjaer, M., and Jørgensen, T. (2007). Associations between overall
physical activity level and cardiovascular risk factors in an adult population.
Eur. J. Epidemiol. 22, 369–378. doi: 10.1007/s10654-006-9100-3
Achten, J., Gleeson, M., and Jeukendrup, A. E. (2002). Determination of the
exercise intensity that elicits maximal fat oxidation. Med. Sci. Sports Exerc. 34,
92–97. doi: 10.1097/00005768-200201000-00015
Ainsworth, B. E., Haskell, W. L., Leon, A. S., Jacobs, D. R. Jr., Montoye, H. J.,
Sallis, J. F., et al. (1993). Compendium of physical activities: classification of
energy costs of human physical activities. Med. Sci. Sports Exerc. 25, 71–80.
doi: 10.1249/00005768-199301000-00011
Allen, J., Sun, Y., and Woods, J. A. (2015). Exercise and the regulation of
inflammatory responses. Prog. Mol. Biol. Transl. Sci. 135, 337–354. doi: 10.1016/
bs.pmbts.2015.07.003
Alpert, S. S. (2005). A limit on the energy transfer rate from the human fat store in
hypophagia. J. Theor. Biol. 233, 1–13. doi: 10.1016/j.jtbi.2004.08.029
Anton, S. D., Duncan, G. E., Limacher, M. C., Martin, A. D., and Perri, M. G.
(2011). How much walking is needed to improve cardiorespiratory fitness? An
examination of the 2008 Physical Activity Guidelines for Americans. Res. Q.
Exerc. Sport 82, 365–370. doi: 10.1080/02701367.2011.10599766
Arai, S. R., Butzlaff, A., Stotts, N. A., and Puntillo, K. A. (2014). Quench the thirst:
lessons from clinical thirst trials. Biol. Res. Nurs. 16, 456–466. doi: 10.1177/
1099800413505900
Arakawa, K., Hosono, A., Shibata, K., Ghadimi, R., Fuku, M., Goto, C., et al.
(2016). Changes in blood biochemical markers before, during, and after a 2-
day ultramarathon. Open Access J. Sports Med. 7, 43–50. doi: 10.2147/OAJSM.
S97468
Arocha Rodulfo, J. I. (2019). Sedentary lifestyle a disease from xxi century. Clin.
Investig. Arterioscler. 31, 233–240. doi: 10.1016/j.arteri.2019.04.004
Frontiers in Physiology | www.frontiersin.org 16 March 2021 | Volume 12 | Article 640710
fphys-12-640710 March 7, 2021 Time: 16:3 # 17
Joerres et al. Physiological Changes During a 100-km-March
Baird, M. F., Graham, S. M., Baker, J. S., and Bickerstaff, G. F. (2012).
Creatine-kinase- and exercise-related muscle damage implications for muscle
performance and recovery. J. Nutr. Metab. 2012:960363. doi: 10.1155/2012/
960363
Banfi, G., Colombini, A., Lombardi, G., and Lubkowska, A. (2012). Metabolic
markers in sports medicine. Adv. Clin. Chem. 56, 1–54. doi: 10.1016/b978-0-
12-394317-0.00015-7
Bassett, D. R. Jr., and Howley, E. T. (2000). Limiting factors for maximum oxygen
uptake and determinants of endurance performance. Med. Sci. Sports Exerc. 32,
70–84. doi: 10.1097/00005768-200001000-00012
Baur, D. A., Bach, C. W., Hyder, W. J., and Ormsbee, M. J. (2016). Fluid retention,
muscle damage, and altered body composition at the Ultraman triathlon. Eur.
J. Appl. Physiol. 116, 447–458. doi: 10.1007/s00421-015-3291-9
Benda, N. M., Hopman, M. T., van Dijk, A. P., Oxborough, D., George, K. P.,
Thijssen, D. H., et al. (2016). Impact of prolonged walking exercise on cardiac
structure and function in cardiac patients versus healthy controls. Eur. J. Prev.
Cardiol. 23, 1252–1260. doi: 10.1177/2047487316631389
Beyer, S. (1990). Gender differences in the accuracy of self-evaluations of
performance. J. Pers. Soc. Psychol. 59, 960–970. doi: 10.3389/fpsyg.2016.01680
Cerqueira, É., Marinho, D. A., Neiva, H. P., and Lourenço, O. (2020). Inflammatory
effects of high and moderate intensity exercise-a systematic review. Front.
Physiol. 10:1550. doi: 10.3389/fphys.2019.01550
Coker, R. H., Weaver, A. N., Coker, M. S., Murphy, C. J., Gunga, H. C., and
Steinach, M. (2017). Metabolic responses to the yukon arctic ultra: longest and
coldest in the world. Med. Sci. Sports Exerc. 49, 357–362. doi: 10.1249/MSS.
0000000000001095
Cowie, M. R., Jourdain, P., Maisel, A., Dahlstrom, U., Follath, F., Isnard, R., et al.
(2003). Clinical applications of B-type natriuretic peptide (BNP) testing. Eur.
Heart J. 24, 1710–1718. doi: 10.1016/s0195-668x(03)00476-7
Coyle, E. F., Coggan, A. R., Hemmert, M. K., and Ivy, J. L. (1986). Muscle glycogen
utilization during prolonged strenuous exercise when fed carbohydrate. J. Appl.
Physiol. 61, 165–172. doi: 10.1152/jappl.1986.61.1.165
Davis, C. E., Williams, D. H., Oganov, R. G., Tao, S. C., Rywik, S. L., Stein, Y., et al.
(1996). Sex difference in high density lipoprotein cholesterol in six countries.
Am. J. Epidemiol. 143, 1100–1106. doi: 10.1093/oxfordjournals.aje.a008686
Deutsche Akkreditierungsstelle GmbH (2020). Available online at: http://www.
dakks.de/as/ast/d/D-ML-17085-01-00.pdf (accessed January 06, 2020).
Doyen, B., Matelot, D., and Carré, F. (2019). Asymptomatic bradycardia amongst
endurance athletes. Phys. Sportsmed. 47, 249–252. doi: 10.1080/00913847.2019.
1568769
Edwards, S., Clow, A., Evans, P., and Hucklebridge, F. (2001). Exploration of the
awakenin/g cortisol response in relation to diurnal cortisol secretory activity.
Life Sci. 68, 2093–2103. doi: 10.1016/s0024-3205(01)00996-1
Eijsvogels, T., George, K., Shave, R., Gaze, D., Levine, B. D., Hopman, M. T., et al.
(2010). Effect of prolonged walking on cardiac troponin levels. Am. J. Cardiol.
105, 267–272. doi: 10.1016/j.amjcard.2009.08.679
Eijsvogels, T. M. H., and Maessen, M. F. H. (2017). Exercise for coronary heart
disease patients: little is good, more is better, vigorous is best. J. Am. Coll.
Cardiol. 70, 1701–1703. doi: 10.1016/j.jacc.2017.08.016
Emed, L. G., Passaglia, D. G., Guerios, S. T., João, P. G., Moser, A. I., Abdalla,
D. S., et al. (2016). Acute modification in plasma lipid levels in ultramarathon
runners. J. Sports Sci. 34, 1657–1661. doi: 10.1080/02640414.2015.1130237
Fallon, K. E. (2001). The acute phase response and exercise: the ultramarathon
as prototype exercise. Clin. J. Sport Med. 11, 38–43. doi: 10.1097/00042752-
200101000-00007
Fikenzer, K., Fikenzer, S., Laufs, U., and Werner, C. (2018). Effects of endurance
training on serum lipids. Vascul. Pharmacol. 101, 9–20. doi: 10.1016/j.vph.2017.
11.005
Ginsburg, G. S., Agil, A., O’Toole, M., Rimm, E., Douglas, P. S., and Rifai,
N. (1996). Effects of a single bout of ultraendurance exercise on lipid
levels and susceptibility of lipids to peroxidation in triathletes. JAMA 276,
221–225.
Global Bmi Mortality Collaboration, Di Angelantonio, E., Bhupathiraju, S. H. N.,
Wormser, D., Gao, P., Kaptoge, S., et al. (2016). Body-mass index and all-cause
mortality: individual-participant-data meta-analysis of 239 prospective studies
in four continents. Lancet 388, 776–786. doi: 10.1016/S0140-6736(16)30175-1
International Association of Ultrarunners (2020). Available online at: http://iau-
ultramarathon.org (accessed July 13, 2019).
Jaffrin, M. Y., and Morel, H. (2008). Body fluid volumes measurements by
impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance
analysis (BIA) methods. Med. Eng. Phys. 30, 1257–1269. doi: 10.1016/j.
medengphy.2008.06.009
Jensen-Urstad, K., Saltin, B., Ericson, M., Storck, N., and Jensen-Urstad, M. (1997).
Pronounced resting bradycardia in male elite runners is associated with high
heart rate variability. Scand. J. Med. Sci. Sports 7, 274–278. doi: 10.1111/j.1600-
0838.1997.tb00152.x
Kang, S. J., Ha, G. C., and Ko, K. J. (2017). Association between resting heart
rate, metabolic syndrome and cardiorespiratory fitness in Korean male adults.
J. Exerc. Sci. Fit. 15, 27–31. doi: 10.1016/j.jesf.2017.06.001
Kannel, W. B., Kannel, C., Paffenbarger, R. S. Jr., and Cupples, L. A. (1987). Heart
rate and cardiovascular mortality: the Framingham Study. Am. Heart J. 113,
1489–1494. doi: 10.1016/0002-8703(87)90666-1
Kasprowicz, K., Ziemann, E., Ratkowski, W., Laskowski, R., Kaczor, J. J., Dadci,
R., et al. (2013). Running a 100-km ultra-marathon induces an inflammatory
response but does not raise the level of the plasma iron-regulatory protein
hepcidin. J. Sports Med. Phys. Fitness 53, 533–537.
Khan, F. Y. (2009). Rhabdomyolysis: a review of the literature. Neth. J. Med. 67,
272–283.
Kim, J., and So, W. Y. (2018). High body mass index is associated with the extent
of muscle damage after eccentric exercise. Int. J. Environ. Res. Public Health
15:1378. doi: 10.3390/ijerph15071378
Kim, Y. J., Shin, Y. O., Lee, J. B., Lee, Y. H., Shin, K. A., Kim, A. C., et al. (2014). The
effects of running a 308 km ultra-marathon on cardiac markers. Eur. J. Sport Sci.
14(Suppl. 1), S92–S97. doi: 10.1080/17461391.2011.654267
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